Novel Image-Guided Percutaneous Lung Tissue Excision Device with Integrated Sealing of Blood Vessels and Airways

This video is part of CTSNet’s 2023 Innovation Video Competition. Watch all entries into the competition, including the winning videos.

This video shows the preclinical use of the minimally invasive targeted resection (MiTR) system, a novel electrosurgical instrument that allows for targeted excision of a lung abnormality while using bipolar radiofrequency energy to seal blood vessels and airways.

References

1. Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA: A Cancer Journal for Clinicians 2022; 72: 7–33.
2. Ostrowski M, Marjański T, Rzyman W. Low-dose computed tomography screening reduces lung cancer mortality. Adv Med Sci 2018; 63: 230–236.
3. Screening for lung cancer with low dose computed tomography (LDCT). CMS.gov Centers for Medicare & Medicaid Services https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=N&ncaid=304 (accessed April 18, 2023).
4. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365: 395–409.
5. de Andrade JR, Rocha RD, Falsarella PM, et al. CT-guided percutaneous core needle biopsy of pulmonary nodules smaller than 2 cm: technical aspects and factors influencing accuracy. J Bras Pneumol 2018; 44: 307–314.

Disclaimer

The named authors are shareholders in, consultants to, or employees of Prana Thoracic, Inc. The authors maintained full control over the study and acknowledge their responsibility for its design, analysis, honesty, and accuracy.

The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.